Clinical Trial Detail

NCT ID NCT01876511
Title Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Advanced Solid Tumor

colorectal cancer

Therapies

Pembrolizumab

Age Groups: senior adult

Additional content available in CKB BOOST